S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

Boglarka Gyurkocza, Stuart Seropian, Hannah Choe, Mark Litzow, Camille Abboud, Nebu Koshy, Patrick Stiff, Benjamin Tomlinson, Sunil Abhyankar, James M Foran, Parameswaran Hari, George Chen, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie Orozco, Katarzyna Jamieson, Margarida Silverman, Koen Van Besien, Michael Schuster, Arjun Law, Sameem Abedin, Karilyn Larkin, Scott Rowley, Pashna Munshi, Rachel Cook, Sebastian Mayer, Moshe Yair Levy, Hillard Lazarus, Brenda Sandmaier, Vijay Reddy, Jennifer Spross, Kathleen Mcnamara, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, John Pagel, Sergio Giralt, Avinash Desai, Rajneesh Nath

Open source

DOI: 10.1097/01.hs9.0000967904.29417.23
Published: 2023-08
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000967904.29417.23,
  title = {S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML},
  author = {Boglarka Gyurkocza and Stuart Seropian and Hannah Choe and Mark Litzow and Camille Abboud and Nebu Koshy and Patrick Stiff and Benjamin Tomlinson and Sunil Abhyankar and James M Foran and Parameswaran Hari and George Chen and Zaid Al-Kadhimi and Partow Kebriaei and Mitchell Sabloff and Johnnie Orozco and Katarzyna Jamieson and Margarida Silverman and Koen Van Besien and Michael Schuster and Arjun Law and Sameem Abedin and Karilyn Larkin and Scott Rowley and Pashna Munshi and Rachel Cook and Sebastian Mayer and Moshe Yair Levy and Hillard Lazarus and Brenda Sandmaier and Vijay Reddy and Jennifer Spross and Kathleen Mcnamara and Elaina Haeuber and Madhuri Vusirikala and Akash Nahar and John Pagel and Sergio Giralt and Avinash Desai and Rajneesh Nath},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000967904.29417.23},
  url = {https://doi.org/10.1097/01.hs9.0000967904.29417.23}
}

RIS

TY  - JOUR
TI  - S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML
AU  - Boglarka Gyurkocza
AU  - Stuart Seropian
AU  - Hannah Choe
AU  - Mark Litzow
AU  - Camille Abboud
AU  - Nebu Koshy
AU  - Patrick Stiff
AU  - Benjamin Tomlinson
AU  - Sunil Abhyankar
AU  - James M Foran
AU  - Parameswaran Hari
AU  - George Chen
AU  - Zaid Al-Kadhimi
AU  - Partow Kebriaei
AU  - Mitchell Sabloff
AU  - Johnnie Orozco
AU  - Katarzyna Jamieson
AU  - Margarida Silverman
AU  - Koen Van Besien
AU  - Michael Schuster
AU  - Arjun Law
AU  - Sameem Abedin
AU  - Karilyn Larkin
AU  - Scott Rowley
AU  - Pashna Munshi
AU  - Rachel Cook
AU  - Sebastian Mayer
AU  - Moshe Yair Levy
AU  - Hillard Lazarus
AU  - Brenda Sandmaier
AU  - Vijay Reddy
AU  - Jennifer Spross
AU  - Kathleen Mcnamara
AU  - Elaina Haeuber
AU  - Madhuri Vusirikala
AU  - Akash Nahar
AU  - John Pagel
AU  - Sergio Giralt
AU  - Avinash Desai
AU  - Rajneesh Nath
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000967904.29417.23
UR  - https://doi.org/10.1097/01.hs9.0000967904.29417.23
ER  -

APA

Gyurkocza, B., Seropian, S., Choe, H., Litzow, M., Abboud, C., Koshy, N., Stiff, P., Tomlinson, B., Abhyankar, S., Foran, J. M., Hari, P., Chen, G., Al-Kadhimi, Z., Kebriaei, P., Sabloff, M., Orozco, J., Jamieson, K., Silverman, M., Besien, K. V., Schuster, M., Law, A., Abedin, S., Larkin, K., Rowley, S., Munshi, P., Cook, R., Mayer, S., Levy, M. Y., Lazarus, H., Sandmaier, B., Reddy, V., Spross, J., Mcnamara, K., Haeuber, E., Vusirikala, M., Nahar, A., Pagel, J., Giralt, S., Desai, A., & Nath, R. (2023). S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML. HemaSphere. https://doi.org/10.1097/01.hs9.0000967904.29417.23

Source records

crossref · retrieved 2026-09-27T03:17:11.369Z